SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600132-19-000062
Filing Date
2019-03-28
Accepted
2019-03-28 08:27:47
Documents
6
Period of Report
2019-05-14
Effectiveness Date
2019-03-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A blphproxymarch2019def.htm DEF 14A 680732
2 a03102bbellerophontherap01.jpg GRAPHIC 319878
3 a03102bbellerophontherapeuti.jpg GRAPHIC 758635
4 aksignaturea02.jpg GRAPHIC 11536
5 blphlogoa49.jpg GRAPHIC 32979
6 ftsignaturea01.jpg GRAPHIC 13086
  Complete submission text file 0001600132-19-000062.txt   2241803
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36845 | Film No.: 19710032
SIC: 2834 Pharmaceutical Preparations